Lv3
220 积分 2023-05-12 加入
Efficacy of PD-1/L1 Inhibitors in Brain Metastases of Non-Small-Cell Lung Cancer: Pooled Analysis from Seven Randomized Controlled Trials
5小时前
已完结
Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis—the META-L-BRAIN Study
27天前
已完结
Opportunities and challenges for non–small cell lung cancer brain metastases in the immunotherapy era
27天前
已完结
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
1个月前
已完结
Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
1个月前
已完结
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
1个月前
已完结
The safety and efficacy of anti-PD-1/PD-L1 monoclonal antibodies for lung cancer brain metastasis: a systematic review and meta-analysis on brain metastasis
1个月前
已完结
Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
2个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
2个月前
已完结
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for TKIs-resistant, EGFR-Mutant, advanced non-small-cell lung cancer: a phase 3 RCTs based meta-analysis
2个月前
已完结
皖公网安备34019202002308
